Histotype, management and outcomes of patients with endobronchial malignancies
| Tumour type and stage | Patient totals n=21 (%) | Management/outcomes | ||
| Squamous cell carcinoma n=10 (47%) | Stage III B | 2 (9) | Chemoradiation | 2 |
| Stage IV | 8 (38) | Chemotherapy and EB stent | 1 | |
| Palliative chemotherapy | 1 | |||
| Hospice | 2 | |||
| Inpatient deaths | 4 | |||
| Adenocarcinoma n=8 (38%) | Stage IA | 1 (5) | LUL wedge resection | 1 |
| Stage IIIB | 1 (5) | Inpatient death | 1 | |
| Stage IV | 6 (29) | Palliative chemotherapy | 3 | |
| Hospice | 2 | |||
| Inpatient death | 1 | |||
| Small cell carcinoma n=3 (14%) | Extensive | 3 (14) | Inpatient deaths | 3 |
EB, endobronchial; LUL, left upper lobe.